The invention will allow surgeons to give patients synthetic heart valves that free them to live lives indistinguishable from ...

The global heart valve devices market size was valued at over USD 10 billion in 2023 and experiencing a significant CAGR of ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world’s most common heart valve disease – aortic stenosis (AS).

The Myval THV series, known for its innovative contributions to transcatheter aortic valve replacement (TAVR) procedures, ...

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein thrombosis, especially during the weeks immediately after surgery. Current ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Insulin resistance can increase the risk of aortic stenosis -- a common heart valve disease -- in men over the age of 45, ...